Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.
about
Key mechanisms governing resolution of lung inflammationHuman immunodeficiency virus infection and pneumothoraxAutophagy modulation as a potential therapeutic target for diverse diseasesMacrolide therapy in respiratory viral infectionsClinical experimentation with aerosol antibiotics: current and future methods of administration.Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data.Lessons learned from 2 decades of CAP therapy data: ways to improve patient managementA multifactoral analysis of 1452 patients for smoking sensation. An outpatient lab experience.Inflammation and Oxidation Biomarkers in Patients with Cystic Fibrosis: The Influence of Azithromycin.Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implicationsJarisch-Herxheimer reaction among HIV-positive patients with early syphilis: azithromycin versus benzathine penicillin G therapy.Systemic exposure of topical erythromycin in comparison to oral administration and the effect on cytochrome P450 3A4 activity.Azithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity.Effectiveness of azithromycin in aspiration pneumonia: a prospective observational studySulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trialMacrolide therapy in cryptogenic organizing pneumonia: A case report and literature review.Efficacy of combination therapy with oseltamivir phosphate and azithromycin for influenza: a multicenter, open-label, randomized studyClarithromycin Attenuates Radiation-Induced Lung Injury in Mice.Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens.Pathogen- and host-directed anti-inflammatory activities of macrolide antibioticsClinical differences between influenza A (H1N1) virus and respiratory infection between the two waves in 2009 and 2010Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disordersMacrolides increase the expression of 11β-hydroxysteroid dehydrogenase 1 in human sinonasal epithelium, contributing to glucocorticoid activation in sinonasal mucosa.The cytokine storm of severe influenza and development of immunomodulatory therapyRemission of ALK-negative primary pulmonary inflammatory myofibroblastic tumor on treatment with clarithromycin: A case report and review of the literatureEffect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa.Linezolid and vancomycin decrease the therapeutic effect of methylene blue-photodynamic therapy in a mouse model of MRSA bacterial arthritisAzithromycin and cough-specific health status in patients with chronic obstructive pulmonary disease and chronic cough: a randomised controlled trial.The double life of antibiotics.Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis.Effects of low-dose clarithromycin added to fluticasone on inflammatory markers and pulmonary function among children with asthma: A randomized clinical trialAnti-inflammatory effects of macrolides in childhood lung diseases.Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.Antimicrobial treatment of non-cystic fibrosis bronchiectasis.Emerging drugs for bronchiectasis: an update.The Value of Macrolide-Based Regimens for Community-Acquired Pneumonia.Do Aging Factors Influence the Clinical Presentation and Management of Chronic Rhinosinusitis?Cystic Fibrosis: Microbiology and Host ResponseImmunomodulatory effect of linezolid on methicillin-resistant Staphylococcus aureus supernatant-induced MUC5AC overexpression in human airway epithelial cells.Chronic Rhinosinusitis and the Evolving Understanding of Microbial Ecology in Chronic Inflammatory Mucosal Disease.
P2860
Q26749606-EFC020D8-6F96-4C0A-8861-B96F2B32E175Q26991924-EB56F5B5-0489-4631-BE67-5C1A3008CE65Q27010076-BF1E23C1-6F10-46A9-AB10-1103316E7C9BQ27027915-2637C9C5-D798-4164-B38B-226C018AAB66Q30448377-0F4964E1-9187-42BE-8C84-621E53C9AC66Q30830558-A925568D-FFCB-443B-884C-C829EBD9C0B3Q31107743-5A76B76E-83A7-49F7-917D-045FD2CBB876Q33634980-D9996665-8A68-48B2-91EA-B6DE9D53C73CQ33794333-220CD064-6B52-45D0-8255-BC346C7E1AB1Q34023899-3749407E-7FCE-476B-AFD9-68B3BE6A44DEQ34112510-583B0380-EBD8-4592-B824-7844857118DAQ34635596-28AFBB65-CAD5-4F21-8BBD-FF834BEC3D15Q34675784-3A490D2E-2823-43D9-8D47-F21BA5EA13D2Q34695463-B38E4E5E-8C30-4367-9545-D82810D5AFB5Q35008674-193D6DCE-6518-48C0-9E8C-BD06B1E4F6C7Q35048531-2A63A807-19CA-4F51-82B8-FCB0863776C7Q35121720-D8948AB5-5106-47BA-A8E9-328C6320AF31Q35675409-D15C3659-0D34-4C6D-86D6-BEF2EFEA1677Q35947509-4AFEA4CC-6153-4563-8F38-4756915D86DAQ36072425-2D3EDD02-8D2F-4614-BBE8-A599208D702FQ36175398-D983485D-7C7C-4F7A-996E-68D589892736Q36387362-4F1C47E7-6B60-4BD9-8DDE-DD86FD89CC84Q36394984-4BC1A6B8-6D2C-47E2-9C1D-4715B6A47A55Q36459143-5C8E9AED-F1D8-44F7-B04A-0CD7A6381FBAQ36640295-BE848329-A69C-4BF5-842D-DD8CE82218CDQ36723908-AC24FC4A-0992-40B1-AE3D-3C6D13BC083EQ36794643-5860C09E-835D-47B5-AA57-89021E30D1BDQ37329250-B2808A19-72A7-426B-AA28-CB6F54E7384FQ37375780-CAEDAE2D-5694-4E12-AFC8-9D8D1126AF94Q37495852-A8EC7C9B-E417-4FF3-8714-AF7577A9BBC9Q37593071-85A2BD4B-B2D8-45D4-AFBC-6230AD89B2F6Q38071534-A5BFA87C-C289-41D0-80FC-D7E752A53C9BQ38177909-52A95C36-0AED-4C84-A682-F8F97FBD0781Q38243206-BDA83124-5FB8-4658-B14F-833648802680Q38367379-A42A4E0C-1E26-4155-B71C-5D84D2EC109AQ38601840-4B6E0D61-496A-4130-888E-CF2C52AF64F9Q38757731-B2C56697-B4F3-42D2-B2A5-E3EEB2FD8CD6Q38911644-1BFF0B54-6EDA-4725-8B78-087A4A643095Q38995787-BAC02E8B-0470-4EDC-B0F8-B7192834421FQ39024902-53511E94-2729-4508-B014-CF71DAFD02A5
P2860
Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Macrolides: from in vitro anti ...... ctice in respiratory diseases.
@en
Macrolides: from in vitro anti ...... ctice in respiratory diseases.
@nl
type
label
Macrolides: from in vitro anti ...... ctice in respiratory diseases.
@en
Macrolides: from in vitro anti ...... ctice in respiratory diseases.
@nl
prefLabel
Macrolides: from in vitro anti ...... ctice in respiratory diseases.
@en
Macrolides: from in vitro anti ...... ctice in respiratory diseases.
@nl
P2093
P2860
P1476
Macrolides: from in vitro anti ...... actice in respiratory diseases
@en
P2093
E Chatzaki
K Zarogoulidis
P Zarogoulidis
P2860
P2888
P304
P356
10.1007/S00228-011-1161-X
P577
2011-11-22T00:00:00Z